draft q1 corporate sjscorecard fy 2013-14€¦ · caesarean section rate : excluding pre-term and...

55
BIG AIM INDICATOR Q1 Q2 Q3 Q4 Annual BIG AIM - Right patient to the right bed (90th %tile LOS) Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual BIG AIM - Right patient to right bed (P4R 90%tile LOS)* 36.5 hrs Hip - Wait Time (Days)* 339 C. Difficile per 1000 patient days* 0.2 Knee - Wait Time (Days)* 470 Falls with harm* 49 Cataract - Wait Time (Days)* 99 Pressure Ulcers* 53 Cancer - Wait Time (Days)* 47 MRSA Incidence Rate per 1000 patient days* 0.12 MRI - Wait Time (Days)* 33 VRE Incidence Rate per 1000 patient days* 0.18 CT - Wait Time (Days)* 29 Ventilator-Associated Pneumonia per 1000 device days* 1.4 Hip - Wait Time (Cases)* 52 Central Line-Associated BSI Rate per 1000 device days* 0.0 Knee - Wait Time (Cases)* 61 Would you recommend - ER Satisfaction* 56% Cataract - Wait Time (Cases)* 592 Hospital Standardized Mortality Ratio* N/A N/A MRI Hours - Wait Time (Hours)* 2,061 90th percentile LOS Non-Admitted High Acuity* 7.1 hrs CT Hours - Wait Time (Hours)* 1,699 90th percentile LOS Non-Admitted Low Acuity* 3.9 hrs General Surgery - Wait Time (Cases)* 297 Chemotherapy Systemic Treatment* TBD TBD Permanent Pacemakers* 31 Chronic Obstructive Pulmonary Disease Cases* 77 % ALC Days* 16.8% Endoscopy* 176 Non-Cardiac Vascular* TBD TBD Congestive Heart Failure Cases* 125 Stroke* 54 Hand Hygiene Compliance 58% Surgical Safety Checklist 100.0% High Risk Medication Safety Events N/A N/A eCare - Overall Project Status TBD TBD 30-Day In-Hospital Mortality Following Acute Myocardial N/A N/A Indicator Q1 Q2 Q3 Q4 Annual 30-Day In-Hospital Mortality Following Stroke N/A N/A Student Learner Satisfaction 82.5% 5-day In-Hospital Mortality Following Major Surgery N/A N/A In-Hospital Hip Fracture in Elderly Patients N/A N/A Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime 1.1% Current Ratio* 1.7 Sick Time (days) 8.97 Total Margin* -0.1 WSIB Lost Time Incidents 4 Acute Inpatient Weighted Cases* 7,212 Ambulatory Visits* 61,446 ER Weighted Cases* 1,204 Inpatient Mental Health Weighted Patient Days* 4,454 Day Surgery Weighted Visits* 757 Nursing Agency Hours 3.2% Full Time RN's 76.5% Results: Legend: Metric underperforming benchmark (>10%) (D) - refers to indicators that are currently in development Metric within 10% of benchmark (A) - refers to indicators which measure performance on an annual basis Metric equal or outperforming benchmark * Required as part of HSAA & Quality Improvement Plan (QIP) Create a Culture of Inquiry and Innovation Put Patients First Enhance the Health of the Communities we Serve Inspire Our People Use Resources Wisely DRAFT Q1 Corporate SJScorecard FY 2013-14 8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 1

Upload: others

Post on 09-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

BIG AIM INDICATOR Q1 Q2 Q3 Q4 Annual

BIG AIM - Right patient to the right bed (90th %tile LOS)

Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 AnnualBIG AIM - Right patient to right bed (P4R 90%tile LOS)* 36.5 hrs Hip - Wait Time (Days)* 339C. Difficile per 1000 patient days* 0.2 Knee - Wait Time (Days)* 470Falls with harm* 49 Cataract - Wait Time (Days)* 99Pressure Ulcers* 53 Cancer - Wait Time (Days)* 47MRSA Incidence Rate per 1000 patient days* 0.12 MRI - Wait Time (Days)* 33VRE Incidence Rate per 1000 patient days* 0.18 CT - Wait Time (Days)* 29Ventilator-Associated Pneumonia per 1000 device days* 1.4 Hip - Wait Time (Cases)* 52Central Line-Associated BSI Rate per 1000 device days* 0.0 Knee - Wait Time (Cases)* 61Would you recommend - ER Satisfaction* 56% Cataract - Wait Time (Cases)* 592Hospital Standardized Mortality Ratio* N/A N/A MRI Hours - Wait Time (Hours)* 2,06190th percentile LOS Non-Admitted High Acuity* 7.1 hrs CT Hours - Wait Time (Hours)* 1,69990th percentile LOS Non-Admitted Low Acuity* 3.9 hrs General Surgery - Wait Time (Cases)* 297Chemotherapy Systemic Treatment* TBD TBD Permanent Pacemakers* 31Chronic Obstructive Pulmonary Disease Cases* 77 % ALC Days* 16.8%Endoscopy* 176Non-Cardiac Vascular* TBD TBDCongestive Heart Failure Cases* 125Stroke* 54Hand Hygiene Compliance 58%Surgical Safety Checklist 100.0%High Risk Medication Safety Events N/A N/AeCare - Overall Project Status TBD TBD30-Day In-Hospital Mortality Following Acute Myocardial N/A N/A Indicator Q1 Q2 Q3 Q4 Annual30-Day In-Hospital Mortality Following Stroke N/A N/A Student Learner Satisfaction 82.5%5-day In-Hospital Mortality Following Major Surgery N/A N/AIn-Hospital Hip Fracture in Elderly Patients N/A N/ACaesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A

Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 AnnualOvertime 1.1% Current Ratio* 1.7Sick Time (days) 8.97 Total Margin* -0.1WSIB Lost Time Incidents 4 Acute Inpatient Weighted Cases* 7,212

Ambulatory Visits* 61,446ER Weighted Cases* 1,204Inpatient Mental Health Weighted Patient Days* 4,454Day Surgery Weighted Visits* 757Nursing Agency Hours 3.2%Full Time RN's 76.5%

Results: Legend:Metric underperforming benchmark (>10%) (D) - refers to indicators that are currently in developmentMetric within 10% of benchmark (A) - refers to indicators which measure performance on an annual basisMetric equal or outperforming benchmark

* Required as part of HSAA & Quality Improvement Plan (QIP)

Create a Culture of Inquiry and Innovation

Put Patients First Enhance the Health of the Communities we Serve

Inspire Our People Use Resources Wisely

DRAFT Q1 Corporate SJScorecard FY 2013-14

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xlsPage 1

Page 2: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

37.9 38.1 38.7 37.7 36.5

37.5 37.5 37.5 37.5 36.9 36.9 36.9 36.9

Indicator Target/Benchmark:

Analysis: Outperforming to benchmark. Q1 results improved over previous four quarters and better than target (36.3% versus 36.9%), while ED demand remains constant at approximately 8,000 patients per monthChanges to over bed capacity reduced time to inpatient bed and overall ED length of stay for admitted patients96 patients placed using overcapacity processfrom Apr 29 – Jun 26

Significance: Part of the MOHLTC ED Pay for Results (P4R) initiative aimed at improving ED treatment time and wait time.

Benchmark LOS @ 90the %tile (hrs)

Definition: The total ER LOS where 9 out of 10 admitted patients complete their visit. ER LOS is defined as the time from triage or registration, whichever comes first, to the time the patient leaves the ER.

P4R Admitted Patients 90th %tile LOS (hrs)

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

CORPORATE PERFORMANCE INDICATOR

Accountability: Dr. Harmantas/M. Vimr

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines: Continue to increase capacity through: Reducing ALC days;Increasing interprofessional staffing (OT, PT, RA, SW) on weekends to continue treatment plans 24/7;Improving access and flow through structural changes;4M piloting improved admission and discharge process to reduce acute LOS

BIG AIM - P4R Admitted Patients 90th Percentile LOS in hours

25.0

27.0

29.0

31.0

33.0

35.0

37.0

39.0

41.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

BIG AIM - P4R Admitted Patients 90th Percentile LOSP4R Admitted Patients 90th %tile LOS (hrs) Benchmark LOS @ 90the %tile (hrs)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 2

Page 3: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

0.61 0.90 0.26 0.23 0.20

0.60 0.60 0.60 0.60

Put Patients First Enhance the Health of the Communities We Serve

CORPORATE PERFORMANCE INDICATOR

Clostridium Difficile

SUCCESS FACTOR:

Inspire Our People Create a Culture of Inquiry and Innovation

Benchmark

Use Resources Wisely

Definition: Number of patients that have developed C. Difficile per 1000 patient days

C. Difficile Infection rate

2012/13 2013/14

Significance: C. Difficile is a species of bacteria which causes diarrhea and other intestinal disease when competing bacteria are wiped out by antibiotics. C. difficult is the most serious cause of antibiotic-associated diarrhea (AAD) and can lead to a severe infection of the colon often resulting from eradication of the normal gut flora. C. Difficile contributes to patient co-morbidities and longer length of stays and it can lead to increased mortality and morbidity.

Accountability: L. O'Drowsky (Interim)

Indicator Target/Benchmark:

Plan for Improvement/Timelines: CQI Reducing C.difficile committee in place with Working Hand Hygiene Group subcommittee. Ongoing eduction to staff. Infection Control resource binder developed and will be distributed to all staff. Emergency Rounds continue and registration triage desk barriers are installed. Clorox company currently reviewing Biomedical Engineering and OR equipment lists to determine if Clorox wipes are safe for use on each equipment type. As well, Clorox company also testing use of Clorox on casings for electronic hand held devices. Antimicrobial Stewardship Program active. Hand Hygiene Products for evaluation pending.

0.00

0.50

1.00

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

C. Difficile Infection rate Benchmark

Clostridium Difficile

Analysis: Outperforming to benchmark. 6 cases this quarter. April 0; May 4 cases; June 2 cases

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls 3

Page 4: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

19 31 32 41 49

25 25 25 24 28 28 28 27

Date

2012/13 2013/14

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

Definition: Number of Falls with Harm as defined by Risk Monitor Pro. Including severity levels 2 (harm - bumps/bruises), 3 (harm - fractures), and 4 (harm - death).

Plan for Improvement/Timelines: Initiate 4L trial: q2hourly rounds, to include turning, repositioning, toileting routine by RN and IP staff Falls Committee co-chairs to meet with each PCM (Medicine/Surgery) to strategize on prevention equipment & activities, conducting safety huddles at daily team talks

Accountability: TBD

Number of Falls with Harm

Benchmark

Significance: To reduce number of falls with harm by a magnitude of 10% by March 31, 2014

Indicator Target/Benchmark:

Analysis: Underperforming to benchmark. Breakdown by severity level (Q1 13/14):Level 2: 43 (fall result in minor harm/damage, additional follow-up/monitoring required)Level 3: 5 (fall results in major permanent harm/damage, or major surgical/medical intervention required)Level 4: 0 (fall results in death, extensive follow-up and investigation required)

Put Patients First Enhance the Health of the Communities We Serve

CORPORATE PERFORMANCE INDICATOR

Falls With Harm

SUCCESS FACTOR:

0100Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2011/12 2012/13

Overall Patient Satisfaction with ER Care Received Overall ER

Satisfaction Score(%)

Benchmark - GTA(Peer 3) ED (%)

0

10

20

30

40

50

60

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Falls With Harm

Number of Falls with Harm Benchmark

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls 4

Page 5: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

24 36 35 51 53

19 18 18 18 50 50 50 50

2013/14

Put Patients First Enhance the Health of the Communities We Serve

Significance: To reduce number of pressure ulcers by a magnitude of 10% by March 31, 2014. To decrease the length of stay in hospital therefore reduce harm to patient.

2012/13

Use Resources Wisely

Definition: Number of nosocomial pressure ulcers as defined in Risk Monitor Pro. including severity levels 1, 2, 3, and 4.

Number of Pressure Ulcers

Inspire Our People Create a Culture of Inquiry and Innovation

Benchmark

CORPORATE PERFORMANCE INDICATOR

Pressure Ulcers

SUCCESS FACTOR:

Accountability: L.O'Drowsky (Interim)

Indicator Target/Benchmark:

Analysis: Within 10% to benchmark. Breakdown by pressure ulcers stages (Q1 13/14):Stage 1: 13 (area of persistent redness)Stage 2: 26 (blister/partial loss of skin layers/not purple)Stage 3 : 3 (deep craters in skin)Stage 4: 0 (muscle/bone exposed)Suspected deep tissue injury : 8 (non-blanchable purple base/blister)Unstageable: 3 (eschar covering visual field of wound bed)

Plan for Improvement/Timelines: Initiate 4L trial: q2hourly rounds, to include turning, repositioning, toileting routine by RN and IP staff Wound Committee chair to meet with each PCM (Medicine/Surgery) to strategize on prevention equipment & activities, conducting safety huddles at daily team talks

0

10

20

30

40

50

60

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Pressure Ulcers

Number of Pressure Ulcers Benchmark

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls 5

Page 6: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

0.19 0.06 0.15 0.09 0.12

0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.63

Indicator Target/Benchmark:

Analysis: Outperforming to benchmark. Outperforming indicator. 4 cases for the quarter. April 3M(1), May 2L Surg (1), June 4L Med (1), 6M (1).

Significance: Methicillin resistant (MRSA) organism or methicillin resistant Staphylococcus aureus: MRSA organisms (commonly nosocomial) can cause serious infections if passed on to someone who is already ill. A lower rate of MRSA incidence indicates a vigilance in infection control practices and an effective Antimicrobial Stewardship Program.

Benchmark Rate

Definition: The hospital-wide colonization and infection rate of nosocomial MRSA measured per 1000 patient days. Benchmark rate is taken from the Canadian Nosocomial Infection Surveillance Program (CNISP); Surveillance for Methicillin resistant Staphylococcus aureus.

MRSA Incidence Rate

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

CORPORATE PERFORMANCE INDICATOR

Accountability: L. O'Drowsky (Interim)

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

MRSA Colonization and Infection Incidence (mandatory)

0.00

0.10

0.20

0.30

0.40

0.50

0.60

0.70

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

MRSA Incidence

MRSA Incidence Rate Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 6

Page 7: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

0.13 0.16 0.03 0.00 0.18

0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15

Use Resources Wisely

Definition: The hospital-wide colonization and infection rate of nosocomial VRE infection measured per 1000 patient days. Benchmark rate is taken from the Canadian Nosocomial Infection Surveillance Program (CNISP); Surveillance for Vancomycin resistant Enterococcus faecalis.

2012/13 2013/14

VRE Incidence Rate

Benchmark Rate

CORPORATE PERFORMANCE INDICATOR

VRE Colonization and Infection Incidence (mandatory)

Create a Culture of Inquiry and InnovationPut Patients First Enhance the Health of the Communities We Serve

SUCCESS FACTOR:

Inspire Our People

Plan for Improvement/Timelines:

Accountability: L. O'Drowsky (Interim)

Indicator Target/Benchmark:

Significance: Vancomycin Resistant Enterococci is an antibiotic resistant organism, easily spread by direct contact. Enterococci is part of the normal bowel flora. The transmission of VRE can be accelerated if found in combination with diarrhea, such as clostridium difficile diarrhea (CAD). Organism is identified and confirmed by public health laboratory.

Analysis: Underperforming to benchmark. Over target at 6 cases for this quarter. April 4M (1), May 3M (1), 2L Surg (2); June ICU (1), 4L Med (1). No clusters or outbreaks.

0.00

0.10

0.20

0.30

0.40

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

VRE Incidence

VRE Incidence Rate Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 7

Page 8: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

0.0 2.4 0.0 2.4 1.4

5.1 5.1 5.1 5.1 5.1 5.1 5.1 5.1

Significance: One component of the Safer Healthcare Now reporting initiative and is required reporting by the MOHLTC.

Analysis: Outperforming to benchmark. ICU continues to have a VAP Incidence Rate below our Benchmark Rate. All aspects of the bundle are initiated and in place.

Plan for Improvement/Timelines: ICU continues with the established process to monitor for VAP. Once identified as a VAP, the bundle compliance is reviewed and any learnings are shared with the team. All VAP are reviewed at monthly ICU POCT Meetings as a standing agenda item.

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

2012/13

Definition: ICU Ventilator-Associated Pneumonia (VAP) cases per 1000 device days. Benchmark taken from Safer HealthCare Now.

2013/14

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Benchmark Rate

Ventilator-Associated Pneumonia (mandatory)

VAP Incidence Rate

0.0

1.0

2.0

3.0

4.0

5.0

6.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

VAP Incidence

VAP Incidence Rate Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 8

Page 9: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2.37 0.00 0.00 0.00 0.00

3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Central Line-Associated Bloodstream Infection Rate (mandatory)

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

Benchmark Rate

Central Line Associated BSI Rate

Significance: One component of the Safer Healthcare Now reporting initiative and is required reporting by the MOHLTC.

Analysis: Outperforming to benchmark. ICU continue to have a BSI Incidence Rate well below our Benchmark Rate. All aspects of the bundle are initiated and in place.

Plan for Improvement/Timelines: ICU continues with the established process to monitor for BSI. Once identified as a BSI, the bundle compliance is reviewed. All BSI are reviewed at monthly ICU POCT Meetings and any learnings from cases are shared with the team. Changes/improvments with the standard at peer hospitals are reviewed and we are presently considering the acquistion of total body drapes for CVL insertions as is now the standard at most of our peer teaching hospitals.

Definition: ICU central line-associated bloodstream infections per 1000 device days. Benchmark taken from Safer HealthCare Now.

2013/142012/13

0.00

1.00

2.00

3.00

4.00

5.00

6.00

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Central Line-Associated BSI Rate

Central Line Associated BSI Rate Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 9

Page 10: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

60.9 63.1 55.0 52.9 56.0

56.3 56.3 56.3 56.3

Accountability: Dr. Harmantas/M. Vimr

2012/13

Use Resources Wisely

Benchmark - GTA (Peer 3) ED (%)

Plan for Improvement/Timelines: -First e-mail feedback survey report delivered to the ACC Manager for comments. -Project manager is communicating with Medical and Administrative directors regarding the ED e-mail survey roll out-Working with ED manager to draft survey-Anticipate ED patient e-mail survey collection by end of August 2013

Analysis: Underperforming to benchmark. Preliminary results for Q1 are higher compared to previous quarter and slightly lower than target (56.0% versus 56.3%). Among all indicators within the Top Priority of the quadrant for the “Would you recommend question” priority matrix for the last 5 quarters, “Rate amount of time spent in ED” consistently has a low score but a high correlation with patient recommendations for ED services and overall patient satisfaction.

2013/14

CORPORATE PERFORMANCE INDICATOR

Would you recommend - ER Satisfaction

Enhance the Health of the Communities We ServeInspire Our People Create a Culture of Inquiry and Innovation

SUCCESS FACTOR:

Definition: Percentage of positive scores on the question that assesses if patient would recommend ED services to their friends and family

Put Patients First

Indicator Target/Benchmark:

Significance: A high degree of patient satisfaction is linked with better outcomes for patients. Important knowledge for improving the quality of those aspects of care that are most important to patients

Would you recommend - ER Satisfaction (%)

46.048.050.052.054.056.058.060.062.064.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Overall Patient Satisfaction with ER Care Received

Would you recommend - ER Satisfaction (%) Benchmark - GTA (Peer 3) ED (%)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 10

Page 11: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3* Q4 Q1 Q2 Q3 Q4

93 93 93 N/A N/A

100 100 100 100 100 100 100 100

Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Benchmark Ratio

Hospital Standardized Mortality Ratio - All Cases (mandatory)

HSMR

2012/13

Definition: The HSMR is based on ICD-10 diagnosis groups that account for 80% of all deaths in acute care hospitals. It is a ratio of the actual number of deaths to the expected number of deaths; adjusted for age, sex and length of stay. Baseline was adjusted from 2004-05 to 2009-10, therefore all historical values have been restated

2013/14

Inspire Our People

Significance: An HSMR greater than 100 suggests that the local mortality rate is higher than the overall average; less than 100 suggests the local mortality rate is lower than average. Included as part of the Quality Improvement Plan (QIP)

Analysis:

Plan for Improvement/Timelines:

Accountability: Dr. Rogovein

Indicator Target/Benchmark: 0

20

40

60

80

100

120

Q1 Q2 Q3* Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

HSMR

HSMR Benchmark Ratio

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 11

Page 12: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

6.4 7.1 7.0 7.0 7.1

7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0

Significance: Included as part of the HSAA Supplementary Request from the TC LHIN.

Analysis: Within 10% to benchmark.

Plan for Improvement/Timelines: Increased by 2 extra assessment areas. Continue with enhanced strategies to improve flow particularly in the Ambulatory Area of ED, shifts in nursing assignments, Pt. Navigator project. Have increased to 3 scribes per day as of Q4 - will increase to 4 PN's daily as of May 2013. Recommendations from ED Operational Review will add strategies to support continued improvement.. Portering initiative in planning stage - should assist with flow.

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

2012/13

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

90th Percentile LOS for Non-admitted High Acuity

Create a Culture of Inquiry and InnovationUse Resources Wisely

TC LHIN Benchmark (hrs)

2013/14

Inspire Our People

Definition: The total ER LOS where 9 out of 10 non-admitted complex (Canadian Triage & Acuity Scale (CTAS) levels I, II, and III) patients complete their visit. ER LOS is defined as the time from triage or registration, whichever comes first, to the time the patient leaves the ER.

90th %tile Non-Admit High Acuity (hrs)

6.0

6.2

6.4

6.6

6.8

7.0

7.2

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

90th Percentile Non-Admit High Acuity

90th %tile Non-Admit High Acuity (hrs) TC LHIN Benchmark (hrs)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 12

Page 13: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

4.1 4.3 4.1 4.1 3.9

4.5 4.5 4.5 4.5 4.4 4.4 4.4 4.4

Significance: Included as part of the HSAA Supplementary Request from the TC LHIN.

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines: Increased by 2 extra assessment areas. Continue with enhanced strategies to improve flow particularly in the Ambulatory Area of ED, shifts in nursing assignments, Pt. Navigator project. Have increased to 3 scribes per day as of Q4 - will increase to 4 PN's daily as of May 2013. Recommendations from ED Operational Review will add strategies to support continued improvement.

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

2012/13

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

90th Percentile LOS for Non-admitted Low Acuity

Create a Culture of Inquiry and InnovationUse Resources Wisely

TC LHIN Benchmark (hrs)

2013/14

Inspire Our People

Definition: The total ER LOS where 9 out of 10 non-admitted minor/uncomplicated (Canadian Triage & Acuity Scale (CTAS) levels IV and V) patients complete their visit. ER LOS is defined as the time from triage or registration, whichever comes first, to the time the patient leaves the ER.

90th %tile Non-Admit Low Acuity (hrs)

3.63.73.83.94.04.14.24.34.44.54.6

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

90th Percentile LOS for Non-Admitted Low Acuity

90th %tile Non-Admit Low Acuity (hrs) TC LHIN Benchmark (hrs)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 13

Page 14: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

Chemotherapy Systemic Treatment - Quality Based Procedure (Cases)

Definition: TBD

Chemo Systemic Treatment (cases)

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

Indicator Target/Benchmark:

Analysis: New QBP - Work underway with TC LHIN to establish indicator targets.

Significance:

Benchmark (cases)

0.0

0.2

0.4

0.6

0.8

1.0

1.2

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Chemotherapy Systemic Treatment - Quality Based Procedure (Cases)

Chemo Systemic Treatment (cases) Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 14

Page 15: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

77

76 77 77 77

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

Chronic Obstructive Pulmonary Disease - Quality Based Procedure (Cases)

Definition: New QBP - Indicator capture the number of Chronic Obstructive Pulmonary Disease cases.

COPD (cases)

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

Indicator Target/Benchmark:

Analysis: Outperforming to benchmark.

Significance:

Benchmark (cases)

50.0

55.0

60.0

65.0

70.0

75.0

80.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

COPD - Quality Based Procedure (Cases) COPD (cases) Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 15

Page 16: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

178 150 141 159 176

166 165 165 165 166 165 165 165

CORPORATE PERFORMANCE INDICATOR

Endoscopy - Quality Based Procedure (Cases)

SUCCESS FACTOR:

Definition: The number of patients who have had a colonoscopy and have either a first degree family member with the disease, or a positive Fecal Occult Blood Test (FOBT).

Enhance the Health of the Communities We Serve

Use Resources Wisely

2012/13

Put Patients FirstInspire Our People Create a Culture of Inquiry and Innovation

Significance: The allocation of volumes will support Ontario's Wait Time Strategy, which includes the development of a comprehensive system to monitor wait times and help ensure that Ontarians receive timely and appropriate access to five select services: cancer surgery, cataract surgery, hip and knee replacements, and MRI and CT exams. The volumes will support this goal and are to assist organizations in reducing waiting times for surgical cases and/or diagnostic imaging.

Benchmark (cases)

Colonoscopy (cases)

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

Analysis: Outperforming to benchmark. The total number of colonoscopy cases has increased this quarter, 10 more than benchmark cases and 17 cases more than last quarter.

Plan for Improvement/Timelines:

2013/14

020406080

100120140160180200

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Endoscopy Cases

Colonoscopy (cases) Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 16

Page 17: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

Non-Cardiac Vascular - Quality Based Procedure (Cases)

Definition: TBD

Non-Cardiac Vascular (cases)

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

Indicator Target/Benchmark:

Analysis: TBD - New QBP

Significance:

Benchmark (cases)

0.0

0.2

0.4

0.6

0.8

1.0

1.2

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Non-Cardiac Vascular - Quality Based Procedure (Cases)

Non-Cardiac Vascular (cases) Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 17

Page 18: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

125

105 105 105 106

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

Congestive Heart Failure - Quality Based Procedure (Cases)

Definition: New QBP - indicator captures the number of Congestive Heart Failure cases.

CHF (cases)

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

Indicator Target/Benchmark:

Analysis:

Significance:

Benchmark (cases)

80.085.090.095.0

100.0105.0110.0115.0120.0125.0130.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Congestive Heart Failure - Quality Based Procedure (Cases)

CHF (cases) Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 18

Page 19: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

54

55 55 55 56

Indicator Target/Benchmark:

Analysis: Within 10% of benchmark.

Significance:

Benchmark (cases)

Definition: New QBP - indicator captures three types of stoke for inpatients: Hemorrhagic, Ischemic or unspecified and Transient Ischemic Attack (TIA).

Stroke (cases)

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

Stroke - Quality Based Procedure (Cases)

40.042.044.046.048.050.052.054.056.058.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Stroke - Quality Based Procedure (Cases)

Stroke (cases) Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 19

Page 20: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

91.0 94.0 94.0 94.0 58.0

92.0 92.0 92.0 92.0 70.0 70.0 70.0 70.0

CORPORATE PERFORMANCE INDICATOR

Accountability: L. O'Drowsky (Interim)

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines: Recognition of bias in current audit process as well as ongoing changes in hand hygiene have prompted a complete assessment and revision of the hand hygiene program. A lead ICP supported by the IC Manager and IC Officer is in place. This program will report through the CQI Reducing C. difficile initiative. Evaluation of electronic based auditing systems is completed with a proposal for purchase and implementation has gone to SLT, approval pending. A comprehensive hand hygiene project action plan with timeline and deliverables is near completion. The Phase I Needs Assessment is completed which included independent hand hygiene audits by trained auditors-LCN (Late Career Nurses), hospital-wide focus groups, Infrastructure and Best Practices Survey Audits (Just Clean Your Hands; WHO Tools). Phase II activities are underway which includes program development using Logic Model, a Mission statement, Communication plan, Action plan, Evaluation plan, Sustainability plan and Program outcome measures and goals. Independent auditing in quarter 4 by LCNs with a sample size of 30 audits per each in-patient unit (n = 17) has shown an overall compliance rate of approximately 50% (range 14% to 61% between providers). Compliance rates in other GTA h it l ith f l h d h i i tl b t 60 t 70% ( bli h d i f ti ) A f A il 1 2013 it lf dit ill t

Hand Hygiene Compliance (mandatory)

Definition: The percentage compliance for before and after patient / patient environment contact by combined categories of health care practitioners. (i.e.. # of times hand hygiene performed before and after contact as a percentage of the # observed hand hygiene indications before and after contact.)

Hand Hygiene Compliance Rate (%)

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

Indicator Target/Benchmark:

Analysis: Underperforming to benchmark. An entirely new process for collecting and measuring HH is underway.

Significance: One component of the Safer Healthcare Now reporting initiative and is required reporting by the MOHLTC.

Benchmark Rate (%)

0.010.020.030.040.050.060.070.080.090.0

100.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Hand Hygiene Compliance Rate

Hand Hygiene Compliance Rate (%) Benchmark Rate (%)

Plan for Improvement/Timelines: April 2013 self auditing ceased and hand hygiene audits conducted by trained observers with inter-related reliability testing. Hand hygiene Working Group a subcommittee of CQI Reducing C. difficile committee. Electronic based auditing system has gone to tender and is expected to be completed by end of July. Educational Road Show is underway.

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 20

Page 21: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

100.0 100.0 100.0 100.0 100.0

100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0

Significance: Included as part of the Quality Improvement Plan (QIP). To improve the reliability of care through the use of Surgical Safety Checklist

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

2012/13

Definition: The number of cases where all three phases of the surgical safety checklist were performed as a percentage of total number of surgeries performed

2013/14

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Benchmark

Surgical Safety Checklist Compliance

Surgical Safety Checklist Compliance %

98.0

98.5

99.0

99.5

100.0

100.5

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Surgical Safety Checklist

Surgical Safety Checklist Compliance % Benchmark

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 21

Page 22: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

15 7 7 7 N/A

8 7 7 7 N/A

Number of high risk medication safety events

Benchmark

Create a Culture of Inquiry and Innovation

2012/13 2013/14

Inspire Our PeopleUse Resources Wisely

Definition: The number of safety events involving the three narcotics; hydromorphone, morphine and oxycodone.

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

Analysis: N/A

Plan for Improvement/Timelines:

Significance: Medication errors contribute to patient harm, the aim is to reduce the number of safety events resulting from high risk medications - narcotics and opioids. Included as part of the Quality Improvement Plan (QIP)

Put Patients First Enhance the Health of the Communities We Serve

CORPORATE PERFORMANCE INDICATOR

HIGH RISK MEDICATION SAFETY EVENTS

SUCCESS FACTOR:

0.0

3.0

6.0

9.0

12.0

15.0

18.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

High Risk NarcoticsNumber of high risk medication safety events Benchmark

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 22

Page 23: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

Yellow Yellow TBD

Benchmark

eCare Project Status

2012/13

Base on eCare Executive Milestone Status Report

Definition: Base on the eCare Executive Milestone Status Report, this metric measures progress on Actual Percentage Completed of activities compared to the Planned Percentage of Completion activities for all plan deliverables.

2013/14

Use Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

eCare - Project Plan Compliance

Accountability: M. Vimr

Indicator Target/Benchmark:

Inspire Our People

Significance: To determine if the project is progressing as planned therefore being able to act proactively to improve performance.

Create a Culture of Inquiry and Innovation

0.00.10.20.30.40.50.60.70.80.91.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

eCare - Project Status

eCare Project Status Benchmark

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 23

Page 24: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

N/A

7.26 7.26 7.26 7.26

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

30 Day In-Hospital Mortality Following Acute Myocardial Infraction (rate per 100)

Definition: The rate of in-hospital deaths due to all causes occurring within 30 days after the first acute myocardial infarction (AMI) admission to an acute care hospital.

Mortality Rate

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

Indicator Target/Benchmark:

Analysis: Q1 coded data not available until September 2013.

Significance:

Benchmark Rate

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

30 Day In-Hospital Mortality Following Acute Myocardial Infraction

Mortality Rate Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 24

Page 25: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

N/A

11.52 11.52 11.52 11.52

Indicator Target/Benchmark:

Analysis: Q1 coded data not available until September 2013.

Significance:

Benchmark Rate

Definition: The rate of in-hospital deaths due to all causes occurring within 30 days after the first stroke admission to an acute care hospital.

Mortality Rate

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

30 Day In-Hospital Mortality Following Stroke (rate per 100)

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

30 Day In-Hospital Mortality Following Stroke (rate per 100)

Mortality Rate Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 25

Page 26: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

N/A

9.38 9.38 9.38 9.38

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

5 Day In-Hospital Mortality Following Major Surgery (rate per 1000)

Definition: The rate of in-hospital deaths due to all causes occurring within five days of major surgery

Mortality Rate

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

Indicator Target/Benchmark:

Analysis: Q1 coded data not available until September 2013.

Significance:

Benchmark Rate

0.01.02.03.04.05.06.07.08.09.0

10.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

5 Day In-Hospital Mortality Following Major Surgery

Mortality Rate Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 26

Page 27: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

N/A

0.62 0.62 0.62 0.62

Indicator Target/Benchmark:

Analysis: Q1 coded data not available until September 2013.

Significance:

Benchmark Rate

Definition: The rate of in-hospital hip fractures among acute care inpatients age 65 and older

Hip Fracture Rate per 1000

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

In-Hospital Hip Fracture in Elderly (65+) Patients (rate per 1000)

0.0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

In-Hospital Hip Fracture in Elderly (65+) Patients

Hip Fracture Rate per 1000 Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 27

Page 28: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

N/A

27.8 27.8 27.8 27.8

CORPORATE PERFORMANCE INDICATOR

Accountability:

SUCCESS FACTOR:

2012/13 2013/14

Put Patients First

Plan for Improvement/Timelines:

Caesarean Section Rate :Excluding Pre-Term and Multiple

Definition: The rate of deliveries via Caesarean section , excluding pre-term and multiple -gestation pregnancies

C- Section Rate per 100

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and InnovationInspire Our People

Use Resources Wisely

Indicator Target/Benchmark:

Analysis: Q1 coded data not available until September 2013.

Significance:

Benchmark Rate

0.0

5.0

10.0

15.0

20.0

25.0

30.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Caesarean Section Rate :Excluding Pre-Term and Multiple

C- Section Rate per 100 Benchmark Rate

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 28

Page 29: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

221 313 305 277 339

170 170 170 170 189 189 189 189

182 182 182 182 182 182 182 182

LHIN Benchmark (days)

Significance: The Ontario government is implementing a plan to increase access and reduce wait times for five major health services: cancer surgery, cardiac procedures, cataract surgery, hip and knee replacements, as well as MRI and CT exams. It will help hospitals and the government to better target their resources to where they will have the most impact.

Analysis: Underperforming to benchmark. Wait time performance in Q1 continues to exceed both LHIN and MOHLTC targets. Hip replacement wait times, at the 90th percentile, by month were as follows: April (402 days), May (368 days), June (308 days). A total of 4 patients exceeded the 182 day MOHLTC benchmark in Q1. In comparison to previous periods, the wait time increased by 62 days from last quarter and increased by 118 days from Q1 2012/13.

Plan for Improvement/Timelines: Wait Time Coordinator along with VP Quality and Chief of Ortho are developing a strategy to improve performance.

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

MOHLTC Benchmark (days)

2012/13

Definition: The number of days 9 out of 10 patients (90th percentile) wait for a hip replacement from the date of decision to treat to day of surgery. Current Wait Time targets are measured by TC LHIN at 170 days

2013/14

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Hip Wait Time Days (mandatory)

Hip Wait Time (days)

050

100150200250300350400

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Hip Wait Time (days)

Hip Wait Time (days) LHIN Benchmark (days) MOHLTC Benchmark (days)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 29

Page 30: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

302 344 386 425 470

170 170 170 170 210 210 210 210

182 182 182 182 182 182 182 182

LHIN Benchmark (days)

Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Knee Wait Time Days (mandatory)

Knee Wait Time (days)

2012/13

Definition: The number of days 9 out of 10 patients (90th percentile) wait for a knee replacement from the date of decision to treat to day of surgery. Current Wait Time targets are measured by TC LHIN at 170 days

2013/14

Inspire Our People

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

MOHLTC Benchmark (days)

Significance: The Ontario government is implementing a plan to increase access and reduce wait times for five major health services: cancer surgery, cardiac procedures, cataract surgery, hip and knee replacements, as well as MRI and CT exams. It will help hospitals and the government to better target their resources to where they will have the most impact.

Analysis: Underperforming to benchmark. Wait time performance continues to climb and has surpassed both LHIN and MOHLTC targets. Knee replacement wait times, at the 90th percentile, by month were as follows: April (526), May (439), June (410). A total of 7 patients exceeded the 182 day MOHLTC benchmark in Q1. In comparison to previous periods, the wait time has grown by 45 days from last quarter and 168 days from Q1 2012/13, reaching its highest level since Q1 2012/13.

Plan for Improvement/Timelines: Wait Time Coordinator along with VP Quality and Chief of Ortho are developing a strategy to improve performance.

050

100150200250300350400450500

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Knee Wait Time (days)

Knee Wait Time (days) MOHLTC Benchmark (days) LHIN Benchmark (days)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 30

Page 31: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

104 108 117 99 99

110 110 110 110 121 121 121 121

182 182 182 182 182 182 182 182

LHIN Benchmark (days)

Significance: The Ontario government is implementing a plan to increase access and reduce wait times for five major health services: cancer surgery, cardiac procedures, cataract surgery, hip and knee replacements, as well as MRI and CT exams. It will help hospitals and the government to better target their resources to where they will have the most impact.

Analysis: Outperforming to benchmark. The 90th percentile wait time performance was the same as last quarter and sit below the LHIN benchmark, reaching its lowest level since Q1 2012/13 . Metric continues to sit well below the MOHLTC target of 182 days. Cataract surgery wait times by month were as follows: April (107), May(89), June (80). In comparison to previous periods, the wait time was same as last quarter and has dropped by 5 days from Q1 2012/13. (Note: LHIN benchmark was changed to 121 days )

Plan for Improvement/Timelines:

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

MOHLTC Benchmark (days)

2012/13

Definition: The number of days 9 out of 10 patients (90th percentile) wait for cataract surgery from the date of decision to treat to day of surgery. Current Wait Time targets are measured by TC LHIN at 100 days

2013/14

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Cataract Wait Time Days (mandatory)

Cataract Wait Time (days)

020406080

100120140160180200

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Cataract Wait Time (days)

Cataract Wait Time (days) MOHLTC Benchmark (days) LHIN Benchmark (days)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 31

Page 32: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

54 50 44 55 47

62 62 62 62 63 63 63 63

84 84 84 84 84 84 84 84

LHIN Benchmark (days)

Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Cancer Wait Time Days (mandatory)

Cancer Wait Time (days)

2012/13

Definition: The number of days 9 out of 10 patients (90th percentile) wait for cancer surgery from the date of decision to treat to day of surgery. Current wait time targets are measured by TC LHIN at 70 days

2013/14

Inspire Our People

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

MOHLTC Benchmark (days)

Significance: The Ontario government is implementing a plan to increase access and reduce wait times for five major health services: cancer surgery, cardiac procedures, cataract surgery, hip and knee replacements, as well as MRI and CT exams. It will help hospitals and the government to better target their resources to where they will have the most impact.

Analysis: Outperforming to benchmark. Wait time performance has improved and continues to sit below both LHIN and MOHLTC benchmarks. In comparison to previous periods, wait times have dropped by 8 days from last quarter and declined by 7 days from the same quarter last year.

Plan for Improvement/Timelines:

0102030405060708090

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Cancer Wait Time (days) LHIN Benchmark (days) MOHLTC Benchmark (days)

Cancer Wait Time (days)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 32

Page 33: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

53 25 22 30 33

110 110 110 110 72 72 72 72

28 28 28 28 28 28 28 28

LHIN Benchmark (days)

Significance: The Ontario government is implementing a plan to increase access and reduce wait times for five major health services: cancer surgery, cardiac procedures, cataract surgery, hip and knee replacements, as well as MRI and CT exams. It will help hospitals and the government to better target their resources to where they will have the most impact.

Definition: The number of days 9 out of 10 patients (90th percentile) wait for an MRI from time the scan is ordered to time until the actual scan is completed. Performance is measured against LHIN benchmark at 115 days.

MRI Wait Time (days)

2012/13 2013/14

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

MOHLTC Benchmark (days)

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First

MRI Wait Time Days (mandatory)

Enhance the Health of the Communities We Serve

0

20

40

60

80

100

120

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

MRI Wait Time (days)

MRI Wait Time (days) MOHLTC Benchmark (days) LHIN Benchmark (days)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 33

Page 34: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

90 74 27 29 29

39 39 39 39 60 60 60 60

28 28 28 28 28 28 28 28

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

CT Wait Time Days (mandatory)

CT Wait Time (days)

2012/13

Definition: The number of days 9 out of 10 patients (90th percentile) wait for a CT from time the scan is ordered to time until the actual scan is completed. Performance is measured against LHIN benchmark at 28 days.

2013/14

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

TC LHIN Benchmark (days)

MOHLTC Benchmark (days)

Significance: The Ontario government is implementing a plan to increase access and reduce wait times for five major health services: cancer surgery, cardiac procedures, cataract surgery, hip and knee replacements, as well as MRI and CT exams. It will help hospitals and the government to better target their resources to where they will have the most impact.

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

0102030405060708090

100

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

CT Wait Time (days) TC LHIN Benchmark (days) MOHLTC Benchmark (days)

CT Wait Time (days)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 34

Page 35: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

40 35 46 32 52

34 34 34 34 36 36 36 35

Significance: The allocation of volumes will support Ontario's Wait Time Strategy, which includes the development of a comprehensive system to monitor wait times and help ensure that Ontarians receive timely and appropriate access to five select services: cancer surgery, cataract surgery, hip and knee replacements, and MRI and CT exams. The volumes will support this goal and are to assist organizations in reducing waiting times for surgical cases and/or diagnostic imaging.

Analysis: Outperforming to benchmark. Q1 actual volume represents 36.36% of the annual Wait Time Strategy / QBP draft target of 143 cases, indicating SJHC is on track to meeting and exceeding the 2013/14 volume allocation. Year-to-date comparison shows hip replacement volumes are up by 30% (12 cases).

Plan for Improvement/Timelines:

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

2012/13

Definition: The number of primary hip replacements performed to meet the volume allocated through Ontario's Wait Time Strategy / Quality Based Procedures (QBP)

2013/14

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Benchmark (cases)

Hip Replacement Wait Time Cases (mandatory)

Hip Replacement Wait Time Volumes

0

10

20

30

40

50

60

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Hip Replacement Cases

Hip Replacement Wait Time Volumes Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 35

Page 36: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

80 55 70 81 61

62 62 62 62 68 67 67 67

Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Benchmark (cases)

Knee Replacement Wait Time Cases (mandatory)

Knee Replacement Wait Time Volumes

2012/13

Definition: The number of primary knee replacements performed to meet the volume allocated through Ontario's Wait Time Strategy / Quality Based Procedures (QBP) .

2013/14

Inspire Our People

Significance: The allocation of volumes will support Ontario's Wait Time Strategy, which includes the development of a comprehensive system to monitor wait times and help ensure that Ontarians receive timely and appropriate access to five select services: cancer surgery, cataract surgery, hip and knee replacements, and MRI and CT exams. The volumes will support this goal and are to assist organizations in reducing waiting times for surgical cases and/or diagnostic imaging.

Analysis: Within 10% of benchmark. Q1 actual volume represents 22.76% of the annual Wait Time Strategy / QBP draft target of 268 cases, indicating SJHC is on track to meeting and exceeding the 2013/14 volume allocation. Year-to-date comparison shows knee replacement volumes are down by 23.75% (or 19 cases).

Plan for Improvement/Timelines:

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark: 0

102030405060708090

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Knee Replacement Cases

Knee Replacement Wait Time Volumes Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 36

Page 37: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

611 483 537 514 592

465 465 465 464 458 457 457 457

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Cataract Wait Time Cases (mandatory)

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

Benchmark (cases)

Cataract Wait Time Volumes

Significance: The allocation of volumes will support Ontario's Wait Time Strategy, which includes the development of a comprehensive system to monitor wait times and help ensure that Ontarians receive timely and appropriate access to five select services: cancer surgery, cataract surgery, hip and knee replacements, and MRI and CT exams. The volumes will support this goal and are to assist organizations in reducing waiting times for surgical cases and/or diagnostic imaging.

Analysis: Outperforming to benchmark. Q1 actual volume represents 32.4% of the annual Wait Time Strategy / QBP target of 1829 cases. This indicates SJHC is on track to meeting and exceeding the 2013/14 volume allocation.

Plan for Improvement/Timelines:

Definition: The number of cataract procedures performed to meet the volume allocated through Ontario's Wait Time Strategy/ Quality Based Procedures (QBP) .

2013/142012/13

0

100

200

300

400

500

600

700

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Cataract Cases

Cataract Wait Time Volumes Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 37

Page 38: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2141 1963 1862 2024 2061

1727 1727 1986 1986 1727Significance: The allocation of volumes will support Ontario's Wait Time Strategy, which includes the development of a comprehensive system to monitor wait times and help ensure that Ontarians receive timely and appropriate access to five select services: cancer surgery, cataract surgery, hip and knee replacements, and MRI and CT exams. The volumes will support this goal and are to assist organizations in reducing waiting times for surgical cases and/or diagnostic imaging.

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

2012/13

Definition: The number of MRI hours performed to meet the volume allocated through Ontario's Wait Time Strategy.

2013/14

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Benchmark (hours)

MRI Wait Time Hours (mandatory)

MRI hours

0200400600800

1000120014001600180020002200

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

MRI HoursMRI hours Benchmark (hours)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 38

Page 39: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

1638 1638 1638 1638 1699

974 974 974 974 974 974 974 974

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

CT Wait Time Hours (mandatory)

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

Benchmark (hours)

CT hours

Significance: The allocation of volumes will support Ontario's Wait Time Strategy, which includes the development of a comprehensive system to monitor wait times and help ensure that Ontarians receive timely and appropriate access to five select services: cancer surgery, cataract surgery, hip and knee replacements, and MRI and CT exams. The volumes will support this goal and are to assist organizations in reducing waiting times for surgical cases and/or diagnostic imaging.

Analysis: Outperforming to benchmark. CT consistently exceeds the Ministry benchmark as the target is based on one scanner and we operate two.

Plan for Improvement/Timelines:

Definition: The number of CT hours performed to meet the volume allocated through Ontario's Wait Time Strategy.

2013/142012/13

0200400600800

10001200140016001800

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

CT Hours

CT hours Benchmark (hours)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 39

Page 40: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1* Q2 Q3 Q4*

271 198 237 232 297

242 242 242 241 232 232 231 231

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

General Surgery (cases)

Significance: The allocation of volumes will support Ontario's Wait Time Strategy, which includes the development of a comprehensive system to monitor wait times and help ensure that Ontarians receive timely and appropriate access to five select services: cancer surgery, cataract surgery, hip and knee replacements, and MRI and CT exams. The volumes will support this goal and are to assist organizations in reducing waiting times for surgical cases and/or diagnostic imaging.

Accountability: Dr. Harmantas/M. Vimr

Indicator Target/Benchmark:

Analysis: Outperforming to benchmark. Q1 estimated volume represents 32% of the Wait Time Strategy annual target of 926 cases, indicating SJHC is on track to meeting the 2013/14 volume allocation. Year-to-date comparison shows cancer surgery volumes are up by 9.6% (or 26 cases). Final Q1 numbers will be confirmed once June 2013 patient charts are coded and abstracted . MOHLTC deadline for coding of first quarter data is August 31, 2013. *Q1 data is an estimate based on single month data (99 x 3 =297)

Plan for Improvement/Timelines:

Benchmark (cases)

Definition: The number of select General Surgery Cases performed to meet the volume allocated through Ontario's Wait Time Strategy. Types of surgeries included in the count are: Anorectal surgery, Cholecystectomy, Intestinal surgery, Groin Hernia Repair and Ventral Hernia Repair.

2012/13 2013/14

Put Patients First Enhance the Health of the Communities We Serve

CORPORATE PERFORMANCE INDICATOR

General Surgery - Wait Time (Cases)

SUCCESS FACTOR:

04080

120160200240280320

Q1 Q2 Q3 Q4 Q1* Q2 Q3 Q4*

2012/13 2013/14

General Surgery- Wait Time (Cases)General Surgery (cases) Benchmark (cases)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 40

Page 41: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

31

30 30 30 29

Accountability: Dr. Harmantas/M. Vimr

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

Definition: Indicator captures the number of Pacemaker cases performed.

Number of Cases

Benchmark

2013/14

Use Resources WiselyInspire Our People

CORPORATE PERFORMANCE INDICATOR

Put Patients First

Cardiac Services - Permanent Pacemakers

SUCCESS FACTOR:

Enhance the Health of the Communities We ServeCreate a Culture of Inquiry and Innovation

Significance:

Indicator Target/Benchmark:

2012/13

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Cardiac Services - Permanent PacemakersNumber of Cases Benchmark

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 41

Page 42: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

21.1 19.0 20.7 20.6 16.8

15.4 15.4 15.4 15.4 15.5 15.5 15.5 15.5

10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0

Create a Culture of Inquiry and Innovation

Significance: Indicates the hospitals ability to access appropriate level of care within health system. (Benchmark is based on our Quality Plan for 2012-13. Target is based on TC LHIN target for 2011-12 as stated in the MLPA.)

Indicator Target/Benchmark:

LHIN Target (%)

2012/13

CORPORATE PERFORMANCE INDICATOR

Put Patients First

Percent ALC Days

SUCCESS FACTOR:

Enhance the Health of the Communities We Serve

Accountability: Dr. Harmantas/M. Vimr

Analysis: Within 10% of benchmark. A marked improvement in performance in Q1 with an absolute decrease in ALC by 3.8%.

Plan for Improvement/Timelines: The MASH Program continues to work with its community partners and the TC CCAC to capitalize on all "Home First" and Aging at Home strategies for ALC patients. During late Q3, a new role was introduced (ALC Strategy Lead) to attempt to better understand ALC pressures (internally and externally) and to develop strategies to reduce ALC volumes and days. The Discharge Operations Team began its work at the start of Q4 to provide oversight to all ALC patient discharge planning.

Definition: Percentage of inpatient days that are designated Alternate Level of Care (ALC), which indicates that Acute level care is no longer required.

% ALC Days (%)

Benchmark (%)

2013/14

Use Resources WiselyInspire Our People

0.0

5.0

10.0

15.0

20.0

25.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Percent ALC Days

% ALC Days (%) Benchmark (%)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 42

Page 43: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

1.1 1.4 1.4 1.5 1.10

1.5 1.5 1.5 1.5 1.06 1.06 1.06 1.06

1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0

Enhance the Health of the Communities We Serve

Inspire Our People

2012/13

Put Patients First

Use Resources Wisely

Create a Culture of Inquiry and Innovation

Accountability: W. Steele

Definition: The number of overtime hours as a percentage of the total paid hours.

Significance: A higher rate of overtime results in a higher cost burden to the hospital. It may indicate staffing shortages and can lead to employee dissatisfaction. Benchmark source: 2012 -OHA HR Benchmarking Survey Report - Region #3 Weighted Average

Analysis: Within 10% of benchmark.

Plan for Improvement/Timelines:

2013/14

Overtime (%)

Indicator Target/Benchmark:

Target (%)

Benchmark (%)

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Overtime

0.00.20.40.60.81.01.21.41.6

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

OvertimeOvertime (%) Benchmark (%)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 43

Page 44: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

9.29 9.21 9.23 9.15 8.97

9.06 9.06 9.06 9.06 8.22 8.22 8.22 8.22

7.20 7.20 7.20 7.20 7.20 7.20 7.20 7.20

Accountability: W. Steele

Definition: Average number of sick leave days per full-time employee across the Health Centre.

Significance: Benchmark source: 2012 -OHA HR Benchmarking Survey Report - Region #3 Weighted Average

Analysis: Within 10% of benchmark. Sick days are now below 9 days on average.

Plan for Improvement/Timelines: Continue to monitor the compliance of the Attendance Management Program (AMP) with respect to Managers meeting with identified employees regarding the application of the AMP Policy.

2013/14

Target (Days)

Indicator Target/Benchmark:

Employee Sick Time (Days)

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Benchmark (Days)

Employee Sick Time

2012/13

Use Resources WiselyInspire Our People Create a Culture of Inquiry and Innovation

0.00

2.00

4.00

6.00

8.00

10.00

12.00

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Employee Sick Time

Employee Sick Time (Days) Benchmark (Days)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 44

Page 45: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2 3 3 4 4

9 9 9 9 9 9 9 9Benchmark

WSIB Lost Time Incidents

2012/13

Use Resources WiselyInspire Our People Create a Culture of Inquiry and Innovation

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We Serve

Accountability: W. Steele

Definition: The total number of WSIB lost time incidents per quarter for SJHC staff.

Significance: An employer of choice is dedicated to the safety of its employees

Analysis: Outperforming to benchmark. There were a total of 4 lost time incidents that occurred in Q1

Plan for Improvement/Timelines:

2013/14

Indicator Target/Benchmark:

WSIB Lost Time Incidents

0123456789

10

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

WSIB Lost Time Incidents

WSIB Lost Time Incidents Benchmark

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 45

Page 46: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

84.1 80.6 79.8 84.1 82.5

80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0

Student Learner Satisfaction (%)

Benchmark (%)

Create a Culture of Inquiry and Innovation

2012/13 2013/14

Inspire Our PeopleUse Resources Wisely

Definition: Student satisfaction with learning experience at St. Joseph's Health Centre. Students from all professions are included in the evaluation.

Accountability: Dr. Rogovein/W. Steele

Indicator Target/Benchmark:

Analysis: Outperforming to benchmark.

*For medical education, 91.8% of learners who responded rated their overall satisfaction with their learning experience at SJHC as excellent or very good.*For the students that go through myself & Susan, 69.5% of learners who responded rated their overall satisfaction with their learning experience at SJHC as excellent or very good.

Plan for Improvement/Timelines: There is a slight downward trend in overall learner satisfaction and the score remains above the benchmark. In analyzing the scores, it may be noted that while learner satisfaction improved for medical trainees, it decreased for learners in other professions. Feedback has been provided by the Interprofessional Education & Collaboration Department to units where performance is low. Ongoing work continues to support the student experience. This quarter we celebrated our second annual Academic Achievement Day - an event created to support recognition around excellence in teaching and learning.

Significance: Timely review of post placement evaluations allows SJHC to respond immediately to student concerns thus ensuring a high quality student experience.

Put Patients First Enhance the Health of the Communities We Serve

CORPORATE PERFORMANCE INDICATOR

Student Learner Satisfaction

SUCCESS FACTOR:

0102030405060708090

100

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Student Learner SatisfactionStudent Learner Satisfaction (%) Benchmark (%)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 46

Page 47: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

1.9 1.9 2.1 1.8 1.7

1.16 1.16 1.16 1.16 1.16 1.16 1.16 1.16

0.80 0.80 0.80 0.80 0.80 0.80 0.80 0.80

CORPORATE PERFORMANCE INDICATOR

Put Patients First

Definition: The number of times the hospital's short-term obligations can be paid using the hospital's short-term assets.

SUCCESS FACTOR:

Current Ratio (mandatory)

Accountability: D. McGregor

2012/13

Significance: Indicates the overall financial health of the organization. The MOHLTC, through the Hospital Accountability Agreement process, has set our benchmark range between 0.8 and 2.0.

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

Indicator Target/Benchmark:

Target (H-SAA Performance Target)

Current Ratio

Benchmark (H-SAA Performance Standard Minimum)

2013/14

Enhance the Health of the Communities We ServeInspire Our People Create a Culture of Inquiry and Innovation

Use Resources Wisely

0.0

0.5

1.0

1.5

2.0

2.5

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Current Ratio

Current RatioTarget (H-SAA Performance Target)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 47

Page 48: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

-0.1 0.7 0.8 0.8 -0.1

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Put Patients First

Total Margin (mandatory)

Enhance the Health of the Communities We Serve

Accountability: D. McGregor

Indicator Target/Benchmark:

Benchmark (%)

*A negative value indicates that expenses have exceeded revenues and a positive value indicates an excess of revenues over expenses.

Significance: Indicates a balanced operating position. The MOHLTC, through the Hospital Accountability Agreement process, has set our benchmark to be 0%.

Analysis: Within 10% of benchmark.

Plan for Improvement/Timelines:

Total Margin (%)

Inspire Our People Create a Culture of Inquiry and InnovationUse Resources Wisely

2012/13

Definition: The percentage by which total revenues exceed total expenses (includes the hospital’s global operating funds, other votes funds and equipment amortization; it excludes commercial operations).

2013/14

-0.2-0.10.00.10.20.30.40.50.60.70.80.9

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Total Margin

Total Margin (%) Benchmark (%)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 48

Page 49: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

6794 6504 6845 6879 7212

5786 5786 5786 5786 5117 5116 5116 5116

6429 6429 6429 6429 5685 5685 5685 5684Target (H-SAA Performance Target)

Accountability: D. McGregor

Plan for Improvement/Timelines:

Acute Inpatient Weighted Cases

Analysis: Outperforming to benchmark.

Indicator Target/Benchmark:

Significance: Resource intensity weights are a relative measure of resource use and one component in cost recovery.

Benchmark (H-SAA Performance Standard Minimum)

CORPORATE PERFORMANCE INDICATOR

Acute Inpatient Weighted Cases (mandatory)

SUCCESS FACTOR:

Use Resources Wisely

Enhance the Health of the Communities We ServeInspire Our People Create a Culture of Inquiry and InnovationPut Patients First

2013/142012/13

Definition: The sum of resource intensity weights (RIW) per patient using CIHI's CMG+ grouping methodology. The hospital total weighted cases is used as the denominator in the cost per weighted case calculation.

0

1000

2000

3000

4000

5000

6000

7000

8000

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Acute Inpatient Weighted Cases

Acute Inpatient Weighted Cases Benchmark (H-SAA Performance Standard Minimum)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 49

Page 50: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

61,837 57,898 65,169 53,043 61,446

52,312 48,751 52,283 50,354 52,937 49,565 55,789 45,409

58,124 54,168 58,092 55,949 58,811 55,065 61,980 50,448

Use Resources Wisely

2012/13

Significance: Health care services provided in an ambulatory care setting can greatly reduce the resource requirements on acute inpatient care, resulting in improved quality of patient care.

2013/14

Target (H-SAA Performance Standard)

Inspire Our People Create a Culture of Inquiry and Innovation

Accountability: D. McGregor

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

Definition: Scheduled/ non-scheduled IP and OP clinic visits and visits in non surgical Day/ Night functional centres, excluding Emergency Department visits and Other Votes.

Indicator Target/Benchmark:

Benchmark (H-SAA Performance Standard Minimum)

Ambulatory Visits

CORPORATE PERFORMANCE INDICATOR

Ambulatory Visits (mandatory)

Enhance the Health of the Communities We Serve

SUCCESS FACTOR:

Put Patients First

010,00020,00030,00040,00050,00060,00070,000

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Ambulatory Visits

Ambulatory Visits Benchmark (H-SAA Performance Standard Minimum)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 50

Page 51: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1* Q2 Q3 Q4

1151 1125 1154 1158 1204

1000 1000 1000 1000 1000 1000 1000 1000

1111 1111 1111 1111 1111 1111 1111 1111

CORPORATE PERFORMANCE INDICATOR

Emergency Department Weighted Cases (New)

SUCCESS FACTOR:

Definition: Total emergency visits adjusted for resource intensity using the Comprehensive Ambulatory Care Classification System (CACS), the methodology that is applied to ambulatory care data.

Enhance the Health of the Communities We ServeInspire Our People Create a Culture of Inquiry and InnovationPut Patients First

2013/142012/13

Target (H-SAA Performance Target)

Use Resources Wisely

Accountability: D. McGregor

Plan for Improvement/Timelines:

ED Weighted Cases

Analysis: Outperforming to benchmark. *Q1 data is based on an estimate of data up to April until verified with Health Records.

Indicator Target/Benchmark:

Significance: CACS weights are a relative measure of resource use. Data using CACS is released annually on May 31; interim data is available quarterly.

Benchmark (H-SAA Performance Standard Minimum)

0

200

400

600

800

1000

1200

1400

Q1 Q2 Q3 Q4 Q1* Q2 Q3 Q4

2012/13 2013/14

ED Weighted Cases

ED Weighted Cases Benchmark (H-SAA Performance Standard Minimum)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 51

Page 52: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

3980 3555 4139 3962 4454

4363 4363 4363 4363 3903 3903 3904 3904

4593 4593 4593 4593 4593 4593 4593 4593Target (H-SAA Performance Target)

Accountability: D. McGregor

Plan for Improvement/Timelines:

Inpatient MH Weighted PD

Analysis: Outperforming to benchmark.

Indicator Target/Benchmark:

Significance: SCIPP weights are a relative measure of resource use. Information is submitted through the Ontario MH Reporting System (OMHRS) and Q1, Q2 & Q3 data is two (2) quarters delayed, while Q4 is four (4) months delayed.

Benchmark (H-SAA Performance Standard Minimum)

CORPORATE PERFORMANCE INDICATOR

Inpatient Mental Health Weighted Patient Days (New)

SUCCESS FACTOR:

Use Resources Wisely

Enhance the Health of the Communities We ServeInspire Our People Create a Culture of Inquiry and InnovationPut Patients First

2013/142012/13

Definition: Measures adult MH total inpatient weighted days of activity using the System for Classification of Inpatient Psychiatry (SCIPP) weighted patient days (SWPD).

0500

100015002000250030003500400045005000

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Inpatient MH Weighted PD

Inpatient MH Weighted PD Benchmark (H-SAA Performance Standard Minimum)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 52

Page 53: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

757

585 585 585 585

650 650 650 650

CORPORATE PERFORMANCE INDICATOR

Day Surgery Weighted Visits (New)

SUCCESS FACTOR:

Put Patients First Enhance the Health of the Communities We ServeInspire Our People Create a Culture of Inquiry and Innovation

Use Resources Wisely

Definition: The sum of resource intensity weights (RIW) per Day surgery patient using CIHI's CMG+ grouping methodology. The hospital total weighted cases is used as the denominator in the cost per weighted case calculation.

2012/13 2013/14

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

Accountability: D. McGregor

Inpatient MH Weighted PD

Benchmark (H-SAA Performance Standard Minimum)

Target (H-SAA Performance Target)

Significance: Resource intensity weights are a relative measure of resource use and one component in cost recovery.

Indicator Target/Benchmark: 500

600

700

800

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Day Surgery Weighted Visits

Inpatient MH Weighted PD Benchmark (H-SAA Performance Standard Minimum)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 53

Page 54: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

4.7 4.4 3.6 5.0 3.2

2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Enhance the Health of the Communities We ServeInspire Our People

2012/13

Put Patients First

Use Resources WiselyCreate a Culture of Inquiry and Innovation

Accountability: D. McGregor

Definition: Inpatient nursing unit and ambulatory care units purchased service hours per inpatient & ambulatory care units total hrs.

Significance: A high degree of patient satisfaction is linked with consistent staff.

Analysis: Underperforming to benchmark. All programs continue to utilize agency. Medicine (3933 hrs) , Surgery (3742 hrs) and ED (1934 hrs) use the most hours, followed closely by WCFH (1736 hrs). MH used the fewest hours at 589.

Plan for Improvement/Timelines:

2013/14

Agency Hours (%)

Indicator Target/Benchmark:

Target (%)

Benchmark (%)

CORPORATE PERFORMANCE INDICATOR

SUCCESS FACTOR:

Nursing Agency Hours

0.0

1.0

2.0

3.0

4.0

5.0

6.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Nursing Agency Hours

Agency Hours (%) Benchmark (%)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 54

Page 55: DRAFT Q1 Corporate SJScorecard FY 2013-14€¦ · Caesarean Section Rate : Excluding Pre-Term and Multiple N/A N/A Indicator Q1 Q2 Q3 Q4 Annual Indicator Q1 Q2 Q3 Q4 Annual Overtime

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

76.0 75.9 76.2 75.9 76.5

70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0

75.0 75.0 75.0 75.0 75.0 75.0 75.0 75.0

Use Resources Wisely

SUCCESS FACTOR:Put Patients First

Accountability: D. McGregor

Significance: The MOHLTC set the ratio of full-time RN's to be maintained at >70% (corridor floor 1%). This promotes the optimal quality of care for patients.

Analysis: Outperforming to benchmark.

Plan for Improvement/Timelines:

Indicator Target/Benchmark:

CORPORATE PERFORMANCE INDICATOR

Inspire Our People Create a Culture of Inquiry and Innovation

Full Time RN's (mandatory)

Enhance the Health of the Communities We Serve

Definition: The number of full time nurses (Registered Nurse) as a percentage of the total nurses employed within the health centre.

2013/14

Target (%)

2012/13

Full Time RN's (%)

Benchmark (%)

66.0

68.0

70.0

72.0

74.0

76.0

78.0

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2012/13 2013/14

Full Time RN's

Full Time RN's (%) Benchmark (%)

8/16/2013 DRAFT Q1 13-14 Corporate Scorecard_3.xls Page 55